Migraine without aura Migraine Propranolol Placebo
Conditions
Interventions
Oral propranolol 1-
3 mg/kg/day in two divided doses,The placebo will be a tablet composed of an inert substance with similar physical characteristics to propranolol tablet.
Experimental Drug,Placebo Comparator Drug
Propranolol ,Placebo
Sponsors
Maulana Azad Medical College, Bahadur shah zafar marg, New Delhi.
Eligibility
Sex/Gender
All
Age
6 Years to 12 Years
Inclusion criteria
Inclusion criteria: • Diagnosed with Migraine without aura as per International Classification of Headache Disorders, 3rd Edition (ICHD-3) (Annexure-4). • Either >3 missed school days or >3 severe headaches per month.
Exclusion criteria
Exclusion criteria: • Diagnosed with another co-existent headache disorder; • Co-existent asthma or cardiovascular disease that preclude the use of propranolol; • Receiving prophylaxis with any medication, currently or in past 3 months; • Receiving any anti-convulsant drug, currently or in past 3 months; and • Receiving Complementary and alternative medications (CAM).
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| Number of migraine attacks 3 months Headache diary | — |
Secondary
| Measure | Time frame |
|---|---|
| the frequency of migraine attacks 3 months manual | — |
Countries
India
Contacts
Public ContactKeerthana Dhanapaul
Postgraduate Resident
Outcome results
None listed